poisar

Stocks · News reference

Citigroup Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $412

Aug 3, 2026, 6:52 PMBenzinga Newsdesk

Citigroup analyst Joanne Wuensch maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $400 to $412.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

WST
Source
benzinga
Observed
Aug 3, 2026, 6:52 PM
Checked
Aug 3, 2026, 6:52 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 27, 2026, 3:31 PMNa

    Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock Up

    Veeva Systems (VEEV) reported Q2 fiscal 2027 adjusted EPS of $2.35, up 18.1% YoY and beating consensus by 5.9%, with revenues rising 17.6% to $928 million. The company raised its fiscal 2027 revenue guidance to $3.682-$3.687 billion and EPS to $9.21. Vault CRM momentum continued with over 180 customers live including five top 20 biopharmas, while the company advanced its AI strategy with Veeva Falcon.

    Read original at zacks-investment-research
    VEEVGMEDWSTCOO